The role of c-Met and VEGFR2 in glioblastoma resistance to bevacizumab

The role of c-Met and VEGFR2 in glioblastoma resistance to bevacizumab

Abstract Dismal prognosis of glioblastoma (GBM) prompts for the identification of response predictors and therapeutic resistance mechanisms of current therapies. The authors investigated the impact of c-Met, HGF, VEGFR2 expression and microvessel density (MVD) in GBM patients submitted to second-lin...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Bruno Carvalho, José Manuel Lopes, Roberto Silva, Joana Peixoto, Dina Leitão, Paula Soares, Ana Catarina Fernandes, Paulo Linhares, Rui Vaz, Jorge Lima
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/8785dff141e34f8482616e3143dc748b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares